Posts | Mounjaro News - Actualite tirzepatide

LLY vs Novo Nordisk 2026: GLP-1 Stocks Compared

Tirzepatide Tied to Less Mortality and AEs Than Semaglutide

Novo Nordisk buoyed by outperforming oral Wegovy in Q1

GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More

France fines Novo Nordisk and Eli Lilly over ads for anti-obesity drugs - Le Monde.fr

‘Next-Gen’ GLP-1 Leads to 16% More Weight Loss. Is It Better Than Zepbound?

Obesity meds push pharma returns higher, overtaking oncology: report - FirstWord Pharma

Lilly lowers the price of Zepbound® (tirzepatide) single-dose vials | Eli Lilly and Company

Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes

Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket